Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cara Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Cara Therapeutics

Cara Therapeutics

Public

Cara Therapeutics, a Connecticut-based medical firm, develops novel drugs for pain and inflammation treatment.

HQ
Stamford, CT, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Cara Therapeutics, based in Stamford, Connecticut, is dedicated to developing novel drugs for the treatment of pain and inflammation, with a particular focus on chronic pruritus. The company aims to transform how pruritus is treated by leveraging proven science and an expert team to create life-changing therapies. Cara Therapeutics serves the U.S. market, addressing a significant need for effective treatments for this debilitating condition.

The company's key achievements include advancing therapies that significantly improve the quality of life for individuals suffering from chronic pruritus. By focusing on innovative solutions, Cara Therapeutics has made a notable impact in the medical field, particularly in the area of pruritus treatment. Their commitment to scientific excellence and patient care underscores their role as a leader in therapeutic development.

Cara Therapeutics - Similar Companies

Lyra Therapeutics logo

Lyra Therapeutics

CarthroniX logo

CarthroniX

carthronix.com

Carmot Therapeutics logo

Carmot Therapeutics

carmot.us

Neurocarrus logo

Neurocarrus

neurocarrus.com

NeuroTherapeutics Pharma logo

NeuroTherapeutics Pharma

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Karyopharm Therapeutics logo

Karyopharm Therapeutics

karyopharm.com

Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals

catalystpharma.com

Pliant Therapeutics logo

Pliant Therapeutics

pliantrx.com

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Pacira BioSciences logo

Pacira BioSciences

pacira.com

Intra-Cellular Therapies logo

Intra-Cellular Therapies

Praeventix logo

Praeventix

praeventix.com

MediciNova logo

MediciNova

medicinova.com

Citrine Medicine logo

Citrine Medicine

Cara Therapeutics - Quick Facts

Who are Cara Therapeutics' competitors?

Companies similar to Cara Therapeutics include Lyra Therapeutics, CarthroniX, Carmot Therapeutics and Neurocarrus.

When was Cara Therapeutics founded?

Cara Therapeutics was founded in 2004.

Where is Cara Therapeutics' headquarters located?

Cara Therapeutics' headquarters is located in Stamford, CT, US.

When was Cara Therapeutics' last funding round?

Cara Therapeutics' most recent funding round was for $40M (USD) in November 2023.

How much has Cara Therapeutics raised to-date?

As of Nov 2, 2023, Cara Therapeutics has raised a total of $517.2M (USD).

How many employees does Cara Therapeutics have?

Cara Therapeutics has 106 employees as of Feb 6, 2024.

Cara Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapeutics
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research